Gene · 4068
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight into the Structural Basis for Dual Nucleic Acid-Recognition by the Scaffold Attachment Factor B2 Protein. | Int J Mol Sci | 2023 | 36834708 | PubTator, text mining | PubMed |
| Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19. | Int J Mol Sci | 2023 | 36834656 | PubTator, text mining | PubMed |
| Peptides That Block RAS-p21 Protein-Induced Cell Transformation. | Biomedicines | 2023 | 36831007 | PubTator, text mining | PubMed |
| Polymeric Nanocomposite Hydrogel Scaffolds in Craniofacial Bone Regeneration: A Comprehensive Review. | Biomolecules | 2023 | 36830575 | PubTator, text mining | PubMed |
| Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma. | Clin Cancer Res | 2023 | 36826995 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis and Clostridium difficile Infection: A Diagnostic Dilemma. | Cureus | 2023 | 36819301 | PubTator, text mining | PubMed |
| The transcriptional program during germinal center reaction - a close view at GC B cells, Tfh cells and Tfr cells. | Front Immunol | 2023 | 36817488 | PubTator, text mining | PubMed |
| Mindfulness: Strategies to implement targeted self-care. | J Interprof Educ Pract | 2023 | 36816353 | PubTator, text mining | PubMed |
| Severe COVID-19-Induced Hemophagocytic Lymphohistiocytosis. | Cureus | 2023 | 36814742 | PubTator, text mining | PubMed |
| Differentiating fulminant EBV infection complicated by HLH from Lymphoma: report of a case and a brief literature review. | Diagn Pathol | 2023 | 36814281 | PubTator, text mining | PubMed |
BOHEMIA: Broad One Health Endectocide-based Malaria Intervention in Africa-a phase III cluster-randomized, open-label, clinical trial to study the safety and efficacy of ivermectin mass drug administration to reduce malaria transmission in two African settings. | Trials | 2023 | 36810194 | PubTator, text mining | PubMed |
| ABCA3-related interstitial lung disease beyond infancy. | Thorax | 2023 | 36808083 | PubTator, text mining | PubMed |
| Identification of germline cancer predisposition variants in pediatric sarcoma patients from somatic tumor testing. | Sci Rep | 2023 | 36805510 | PubTator, text mining | PubMed |
| Pathologic and molecular insights in nodal T-follicular helper cell lymphomas. | Front Oncol | 2023 | 36793612 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and gastric antral foveolar hyperplasia. | Hum Genet | 2023 | 36773065 | PubTator, text mining | PubMed |
| A Comparative Analysis of Bi-Portal Endoscopic Spine Surgery and Unilateral Laminotomy for Bilateral Decompression in Multilevel Lumbar Stenosis Patients. | J Clin Med | 2023 | 36769686 | PubTator, text mining | PubMed |
| Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature. | Cells | 2023 | 36766791 | PubTator, text mining | PubMed |
| Histological Changes in Portal Cavernoma Cholangiopathy. | Diagnostics (Basel) | 2023 | 36766540 | PubTator, text mining | PubMed |
| PARP Inhibitors and Proteins Interacting with SLX4. | Cancers (Basel) | 2023 | 36765954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4068/papers?page=33